欢迎来到麦多课文档分享! | 帮助中心 海量文档,免费浏览,给你所需,享你所想!
麦多课文档分享
全部分类
  • 标准规范>
  • 教学课件>
  • 考试资料>
  • 办公文档>
  • 学术论文>
  • 行业资料>
  • 易语言源码>
  • ImageVerifierCode 换一换
    首页 麦多课文档分享 > 资源分类 > PDF文档下载
    分享到微信 分享到微博 分享到QQ空间

    ASTM F2024-2000 Standard Practice for X-ray Diffraction Determination of Phase Content of Plasma-Sprayed Hydroxyapatite Coatings 《羟磷灰石等离子喷镀层相含量的X射线衍射测定标准实施规范》.pdf

    • 资源ID:536324       资源大小:50.26KB        全文页数:4页
    • 资源格式: PDF        下载积分:5000积分
    快捷下载 游客一键下载
    账号登录下载
    微信登录下载
    二维码
    微信扫一扫登录
    下载资源需要5000积分(如需开发票,请勿充值!)
    邮箱/手机:
    温馨提示:
    如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
    如需开发票,请勿充值!如填写123,账号就是123,密码也是123。
    支付方式: 支付宝扫码支付    微信扫码支付   
    验证码:   换一换

    加入VIP,交流精品资源
     
    账号:
    密码:
    验证码:   换一换
      忘记密码?
        
    友情提示
    2、PDF文件下载后,可能会被浏览器默认打开,此种情况可以点击浏览器菜单,保存网页到桌面,就可以正常下载了。
    3、本站不支持迅雷下载,请使用电脑自带的IE浏览器,或者360浏览器、谷歌浏览器下载即可。
    4、本站资源下载后的文档和图纸-无水印,预览文档经过压缩,下载后原文更清晰。
    5、试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。

    ASTM F2024-2000 Standard Practice for X-ray Diffraction Determination of Phase Content of Plasma-Sprayed Hydroxyapatite Coatings 《羟磷灰石等离子喷镀层相含量的X射线衍射测定标准实施规范》.pdf

    1、Designation: F 2024 00Standard Practice forX-ray Diffraction Determination of Phase Content of Plasma-Sprayed Hydroxyapatite Coatings1This standard is issued under the fixed designation F 2024; the number immediately following the designation indicates the year oforiginal adoption or, in the case of

    2、 revision, the year of last revision. A number in parentheses indicates the year of last reapproval. Asuperscript epsilon (e) indicates an editorial change since the last revision or reapproval.1. Scope1.1 This practice is for the determination, by the ReferenceIntensity Ratio External Standard Meth

    3、od, of the percent byweight of the crystalline phases, hydroxyapatite (HA), beta-(whitlockite) tricalcium phosphate (b-TCP), and calcium oxide(CaO) in coatings deposited upon metallic substrates byplasma-spraying hydroxyapatite.1.2 A major component in plasma-sprayed HA coatingsother than HA is expe

    4、cted to be amorphous calcium phosphate(ACP). Crystalline components other than HA that may bepresent include alpha- and beta- (whitlockite) tricalcium phos-phates, tetracalcium phosphate (TTCP), calcium oxide, andcalcium pyrophosphates. Quantification of the minor crystal-line components has proven

    5、to be very unreliable due toextreme overlap and confounding of X-ray diffraction peaks.Therefore, this practice addresses the quantification of onlyHA, b-TCP, and CaO.1.3 This practice was developed for plasma-sprayed HAcoatings with HA contents of at least 50 % of the total coating.It is recognized

    6、 that the analysis of the crystalline componentsuses diffraction from regions of the pattern that also includes asmall contribution from the amorphous component. However,within the limits of applicability of this practice, the effect ofsuch interference is believed to be negligible.1.4 The coating a

    7、nalyzed shall be produced and processedunder equivalent manufacturing conditions to that on thedevice of interest.1.5 This practice requires the use of monochromated copperKa radiation and flat samples.1.6 This standard does not purport to address all of thesafety concerns, if any, associated with i

    8、ts use. It is theresponsibility of the user of this standard to establish appro-priate safety and health practices and determine the applica-bility of regulatory limitations prior to use.2. Referenced Documents2.1 ASTM Standards:F 1185 Specification for Composition of Ceramic Hydroxy-lapatite for Su

    9、rgical Implants2F 1609 Specification for Calcium Phosphate Coatings forImplantable Materials23. Terminology3.1 Definitions:3.1.1 crystalline phases:Chemical and MineralNamesFormula PDF Card No.3whitlockitebeta-tricalcium phosphateb-Ca3(PO4)29-169calcium phosphatealpha-tricalcium phosphatea-Ca3(PO4)2

    10、9-348limecalcium oxideCaO 37-1497hydroxyapatite(hydroxylapatite)Ca5(PO4)3OH 9-4323.2 plasma-sprayed hydroxyapatite coatinga coating,consisting of at least 50 % hydroxyapatite by weight, preparedby plasma-spraying hydroxyapatite on a substrate.4. Significance and Use4.1 Calcium phosphate coatings hav

    11、e been shown in animaland clinical studies to be biocompatible and to enhance theearly attachment of bone to implant surfaces (see Refs. 1-5)44.2 It is believed that the form of calcium phosphateceramic and its purity with respect to secondary crystallinephases and amorphous material have an effect

    12、on its physical,mechanical, and biological properties. However, no definitivestudies of effects on biological properties have been completed.To achieve reproducible clinical results and to permit thedetermination of the effects of properties of the coating onbiological performance, it is essential t

    13、hat the properties ofboth clinical and experimental materials be well-characterizedand consistent.1This practice is under the jurisdiction of ASTM Committee F04 on Medical andSurgical Materials and Devices and is the direct responsibility of SubcommitteeF04.13 on Ceramic Materials.Current edition ap

    14、proved May 10, 2000. Published Aug. 2000.2Annual Book of ASTM Standards, Vol 13.01.3Joint Committee on Powder Diffraction Standards, Swarthmore, PA.4The boldface numbers in parentheses refer to the list of references at the end ofthis standard.1Copyright ASTM International, 100 Barr Harbor Drive, PO

    15、 Box C700, West Conshohocken, PA 19428-2959, United States.4.3 This practice provides procedures for determination ofthe percentage by weight of the crystalline phases identified ashydroxyapatite, b-TCP and CaO in plasma-sprayed hydroxya-patite coatings.5. Quantitative Phase Analysis by the External

    16、 StandardTechnique5.1 The external standard technique allows the determina-tion of weight fractions of individual phases in a mixturecontaining an amorphous fraction by comparison of the inte-grated intensity of one or more peaks from the phase(s) ofinterest to the external standard under identical

    17、instrumentalconditions (6). The sample analyzed may be a solid such as aplasma-sprayed coating or may be a powder. The massabsorption coefficients of the sample and standard must beknown.5.2 The weight fraction of the analyte phase in the mixtureis given by Equation 11 of Ref (6), as follows:Wi5SIih

    18、klIiRELDSxmxsDS1IsPure RIRiD(1)where:Iihkl= integrated intensity of the analyte phase (hkl) peakor sum of peaks,IiREL= relative intensity of the analyte phase (hkl) peak orsum of peaks,xm= mass absorption coefficient of the mixture,xs= mass absorption coefficient of the standard,IsPure= integrated i

    19、ntensity of the most intense peak of thepure standard measured under identical condi-tions, andRIRi= reference intensity ratio of the analyte phase to thestandard.Values of the relative intensities, mass absorption coeffi-cients, and reference intensity ratios which have been mea-sured for HA, b-TCP

    20、, and CaO are given in Appendix X1.6. Procedure6.1 Sample Preparation:6.1.1 Plasma sprayed coating samples in the form of flatcoupons of nominal dimensions 2.5 by 2.5 by 0.6 cm (1 by 1by 0.125 in.) may be analyzed directly on the coated surface.The coating must be at least 44 m thick to provide a sa

    21、mpleopaque to the X-ray beam. Thinner samples must be removedfrom the substrate and either deposited in a layer of at least44-m thickness and area sufficient to exceed the dimensionsof the irradiated area.6.1.2 Reliable quantitative analysis cannot be performed byX-ray diffraction on curved surfaces

    22、 because of errors causedby absorption and defocusing.6.1.3 Microabsorption caused by variations in either particlesize or surface roughness will produce errors in the measureddiffracted intensity. The effective particle size and variation insurface roughness of the alpha-corundum external standardm

    23、ust be less than 5 m.6.2 X-ray Equipment:6.2.1 A standard Bragg-Brentano focusing diffractometerequipped with a pyrolytic graphite monochromator is recom-mended. Because of the need to resolve closely spaced andoverlapping peaks, a diffracted beam monochromator is re-quired unless a solid-state dete

    24、ctor is used. Linearity of theinstrument and associated electronics must be verified dailyprior to utilizing this method. Use of NIST silicon powderstandard, SRM 640 is suggested.56.2.2 An X-ray source with a copper target is required.Characteristic copper radiation provides the needed X-raydiffract

    25、ion peak resolution and allows for separation of peaksfrom contaminant phases at a suitable range of diffractionangles from nominally 20 to 60 2u. A 1.0 incident beamdivergence, a 0.2 receiving slit, and soller slits in eitherincident or diffracted beam, or both, are suitable.6.3 X-ray Method and Da

    26、ta Reduction Strategy:6.3.1 Collect a diffraction pattern from 20 to 60 2u at 0.02increments for a minimum of 1s/point.6.3.2 X-ray diffraction peaks (or peak groups) from thecrystalline phases must be separated in order to quantify theHA content. The following outline provides a data reductionstrate

    27、gy in order to provide the integrated intensities necessaryto determine the HA, b-TCP, and CaO content of mixtures ofamorphous calcium phosphate, a-TCP, b-TCP, CaO,b-Ca2P2O7, tetracalcium phosphate, and hydroxyapatite. Ac-complish the determination of integrated intensities usingcomputer techniques,

    28、 with least-squares fitting of the selectedpeak shape to the experimental data. Manual fitting of peak andbackground is not permitted under this standard practice.6.3.2.1 Obtain the b-TCP content by integration from 30.5to 31.5 2u. The b-TCP peak being used for quantification isthe (0 2 10) peak. Th

    29、is region is integrated by assuming a linearbackground and a Pearson VII functional form of the peakssurrounding the region.6.3.2.2 Determine the calcium oxide content by integrationfrom 37.0 to 38.5 2u and correct for the b-TCP (1 2 11) and(315) peaks. This region contains the 100 % (200) calciumox

    30、ide peak, and is integrated by assuming a linear form to thebackground.6.3.2.3 Finally, determine by integration the region from38.5 to 59.0 2u HA and correct for interference by b-TCP andcalcium oxide. A large angular range is used in order to use asmany peaks as possible and to reduce the effects

    31、of preferredorientation. Again, this region is integrated assuming a linearform of the background.6.3.3 Perform the analysis as an external standard techniquewith reference to an alpha-corundum standard, using therelative intensities, mass absorption coefficients, and referenceintensity ratios shown

    32、 in Appendix X1. Reference intensityratios determined experimentally using the equipment andconditions used for analysis of unknown samples may besubstituted for those shown, provided that their validity underthe experimental conditions used for analysis has been verifiedusing known standards. An ex

    33、ample calculation is shown asAppendix X2.6.3.4 Verify the validity of the analytical procedures appliedusing known mixtures of powders ranging from nominally 50to 95 % hydroxyapatite. Conduct periodic revalidation (at least5Available from National Institute of Standards and Technology (NIST), 100Bur

    34、eau Dr., Stop 3460, Gaithersburg, MD 20899-3460.F2024002annually) of instrument conditions and analytical techniqueusing retained plasma-sprayed hydroxyapatite samples.7. Report7.1 Report following information:7.1.1 Sample identification,7.1.2 Condition of analyzed sample, as-sprayed coating oncoupo

    35、n or powder spalled from sample,7.1.3 Analytical results expressed as percent hydroxyapa-tite, percent b-TCP, and percent CaO relative to the entiresample,7.1.4 Balance expressed as balance-amorphous calciumphosphate (ACP) and other minor phases, and7.1.5 Statistical variability of the results based

    36、 on thevariability in the RIR values (shown in Table X1.1) andinstrumental conditions.7.2 Further reporting by the device manufacturer shallinclude any treatment applied to the coating after plasma-spraying.8. Precision and Bias8.1 The precision and bias of this practice are currentlybeing determine

    37、d in an interlaboratory test program. Individualexperience indicates that reproducibility is on the order of63 % for determination of the HA content of plasma-sprayedcoatings.9. Keywords9.1 amorphous calcium phosphate (ACP); hydroxyapatitecoatings; hydroxyapatite (HAP); hydroxylapatite coatings;phas

    38、e analysis; tricalcium phosphate; whitlockiteAPPENDIXES(Nonmandatory Information)X1. REFERENCE VALUES FOR ANALYSISX2. EXAMPLE CALCULATIONX2.1Phase Net Intensity (after correction),counts s/b-TCP 23.9CaO 12.4HA 603.2Standard 989.0X2.2 The weight percentages are determined from Equa-tion 11 of Ref (6)

    39、 with the RIR, Irel, and mass absorptioncoefficients from Appendix X1.Wb2TCP5S23.91DS87.2331.78DS1989.0 1.146D5 0.058 5 5.8 %(X2.1)WCaO5S12.41DS87.2331.78DS1989.0 3.375D5 0.010 5 1.0 %(X2.2)WHA5S603.22.16DS87.2331.78DS1989.0 1.276D5 0.607 5 60.7 %(X2.3)TABLE X1.1 Experimentally Determined Reference

    40、IntensityRatios (RIR) Relative to Alpha-Corundum, aAl2O3Phase RIRHydroxyapatite (commercial powder) 1.276 6 0.001b-TCP 1.146 6 0.004CaO 3.375 6 0.004TABLE X1.2 Combined Relative Intensities for the IntegrationRegions Indicated (6)Phase Range 2u, IRelHydroxyapatite 38.5 - 59.0 2.16 6 0.02b-TCP 30.5 -

    41、 31.637.0 - 38.538.5 - 59.01.00 6 0.000.145 6 0.0012.35 6 0.01CaO 37.0 - 38.538.5 - 59.01.00 6 0.001.32 6 0.007TABLE X1.3 Mass Absorption CoefficientsPhases(s) Mass Absorption CoefficientCa-P from hydroxyapatite (all phases) xm= 87.23Alpha-corundum, aAl2O3xs= 31.78F2024003REFERENCES(1) Cook, S.D., T

    42、homas, K.A., Kay, J.F., and Jarcho, M.,“Hydroxylapatite-Coated Titanium for Orthopedic Implant Applica-tions,” Clinical Orthopaedics, Vol 232, 1988, p. 225.(2) Cook, S.D., Kay, J.F., Thomas, K.A., and Jarcho, M., “InterfaceMechanics and Histology of Titanium and Hydroxylapatite-CoatedTitanium for De

    43、ntal Implant Applications,” International Journal ofOral and Maxillofacial Implants, Vol 2, 1987, p. 15.(3) Kent, J.N., Block, M.S., Finger, I.M., Guerra, L.S., Larsen, H., andMisiek, D.J., “Biointegrated Hydroxylapatite-Coated Dental Implants:5-Year Clinical Observations,” Journal of the American D

    44、ental Asso-ciation, Vol 121, 1990, p. 138.(4) DAntonio, J.A., Capello, W.N., and Jaffe, W.L., “Hydroxylapatite-Coated Hip Implants: Multicenter Three-Year Clinical and Roentgeno-graphic Results,” Clinical Orthopaedics, Vol 285, 1992, p. 102.(5) Thomas, K.A., “Hydroxyapatite Coatings,” Orthopedics, V

    45、ol 17, 1994,p. 267.(6) Prevey, P.S., and Rothwell, R.J., “X-ray Diffraction Characterization ofPercent Crystallinity and Contaminants in Plasma-Sprayed Hydroxy-lapatite Coatings,” Characterization and Performance of CalciumPhosphate Coatings for Implants, ASTM STP 1196, Emanuel Horowitzand Jack E. P

    46、arr, eds., American Society for Testing and Materials,Philadelphia, PA, 1994, p. 63.ASTM International takes no position respecting the validity of any patent rights asserted in connection with any item mentionedin this standard. Users of this standard are expressly advised that determination of the

    47、 validity of any such patent rights, and the riskof infringement of such rights, are entirely their own responsibility.This standard is subject to revision at any time by the responsible technical committee and must be reviewed every five years andif not revised, either reapproved or withdrawn. Your

    48、 comments are invited either for revision of this standard or for additional standardsand should be addressed to ASTM International Headquarters. Your comments will receive careful consideration at a meeting of theresponsible technical committee, which you may attend. If you feel that your comments

    49、have not received a fair hearing you shouldmake your views known to the ASTM Committee on Standards, at the address shown below.This standard is copyrighted by ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959,United States. Individual reprints (single or multiple copies) of this standard may be obtained by contacting ASTM at the aboveaddress or at 610-832-9585 (phone), 610-832-9555 (fax), or serviceastm.org (e-mail); or through the ASTM website(www.astm.org).F2024004


    注意事项

    本文(ASTM F2024-2000 Standard Practice for X-ray Diffraction Determination of Phase Content of Plasma-Sprayed Hydroxyapatite Coatings 《羟磷灰石等离子喷镀层相含量的X射线衍射测定标准实施规范》.pdf)为本站会员(figureissue185)主动上传,麦多课文档分享仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文档分享(点击联系客服),我们立即给予删除!




    关于我们 - 网站声明 - 网站地图 - 资源地图 - 友情链接 - 网站客服 - 联系我们

    copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
    备案/许可证编号:苏ICP备17064731号-1 

    收起
    展开